CMS to cover approved Alzheimer’s drugs — with some strings attached

The latest stories trending on MedCity News.

Editor's Pick

Top Story CMS Will Cover Approved Alzheimer's Drugs, But It Still Wants More Evidence Medicare will cover Alzheimer's disease drugs granted traditional FDA approval, CMS announced. But the decision keeps the spirit of an earlier coverage determination, which called for the gathering of more evidence about the safety and efficacy of these therapies. Sponsored Content MedCity Pivot Podcast: It's Time To Talk About Responsible AI Presented by MedCity News & Carta Healthcare A conversation with Suchi Saria, associate professor of medicine at John Hopkins University and director of its Machine Learning and Healthcare Lab about responsible AI. Click here to listen! Get Your Digital Health Tickets Now Enjoy extra savings when you purchase your extreme early bird INVEST Digital Health 2023 ticket now. Priced at only $295. Join us at Pegasus Park in Dallas, TX for a riveting day of content and networking. Register Now

Featured News

It's Time for Healthcare To Embrace Patient-Friendly Language Recent regulations from the Office of the National Coordinator for Health IT (ONC) and Centers […] Report: 22% of People With a Behavioral Health Condition Account for 41% of Healthcare Spend About 87% of those with a behavioral health condition also have one or more medical conditions, according to a new analysis from the Evernorth Health Research Institute. Interoperability: Past, Present, and Future A new decentralized network of the future exists and is in operation today. Large payers and providers are already beginning to use it for administrative transactions, although clinical transactions are also envisioned. Inside One Philadelphia Doctor's DIY Method to Tackle Health Inequity Dr. Ala Stanford, founder of the Black Doctors Covid-19 Consortium, provided hundreds of thousands of Covid-19 tests and vaccines to Black and Brown people in Philadelphia's underserved neighborhoods during the pandemic. In her view, her was impactful because she acted promptly and focused on community-based patient engagement. Why One Analyst Is Encouraged by Healthcare IT's Fundraising Rebound Healthcare IT companies experienced a bounceback in venture capital deal activity during Q1 of 2023. Rebecca Springer, PitchBook 's lead healthcare analyst, said she is optimistic that healthcare IT startups will be able to keep this momentum going, especially those focused on staffing and value-based care enablement. Pfizer's RSV Vaccine Wins FDA Approval on Heels of Regulatory Nod for GSK Pfizer's Abrysvo is now approved for preventing illness caused by respiratory syncytial virus, or RSV, in adults 60 and older. The regulatory decision comes weeks after GSK won approval for its RSV vaccine, Arexvy.

Resources

Startup 101: Providing Best Practices for Healthcare Entrepreneurs Get the tools necessary to make the right decisions, know what strategies to avoid, and learn how to approach potential healthcare customers. Download Now

MedCity News • PO Box 901 • New York, NY unsubscribe